Actuate Therapeutics Inc (ACTU) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Actuate Therapeutics Inc (ACTU) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $48.3M, listed on NASDAQ, employing roughly 10 people, carrying a beta of 0.53 to the broader market. Actuate Therapeutics, Inc. Led by Daniel Schmitt, public since 2024-08-13.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ACTU as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →